Display options
Cite
Rostami P, Setoodeh A, Rabbani A, et al. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Iran J Pediatr. 2014;24(2):173-8
Rostami, P., Setoodeh, A., Rabbani, A., Nakhaei-Moghadam, M., Najmi-Varzaneh, F., & Rezaei, N. (2014). A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Iranian journal of pediatrics, 24(2), 173-8.
Rostami, Parastoo, et al. "A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus." Iranian journal of pediatrics vol. 24,2 (2014): 173-8.
Rostami P, Setoodeh A, Rabbani A, Nakhaei-Moghadam M, Najmi-Varzaneh F, Rezaei N. A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus. Iran J Pediatr. 2014 Apr;24(2):173-8. PMID: 25535536; PMCID: PMC4268837.
Copy Download .nbib Format: NLM
Share it on

Iran J Pediatr. 2014 Apr;24(2):173-8.

A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus.

Iranian journal of pediatrics

Parastoo Rostami, Aria Setoodeh, Ali Rabbani, Maryam Nakhaei-Moghadam, Farnaz Najmi-Varzaneh, Nima Rezaei

Affiliations

  1. Department of Pediatrics;
  2. Department of Pediatrics; ; Growth and Development Research Center;
  3. Research Center for Immunodeficiencies, Children's Medical Center;
  4. Research Center for Immunodeficiencies, Children's Medical Center; ; Department of Immunology, Molecular Immunology Research Center, School of Medicine; Tehran University of Medical Sciences , Tehran, Iran.

PMID: 25535536 PMCID: PMC4268837

Abstract

OBJECTIVE: Appropriate treatment of patients with Type 1 diabetes mellitus (T1DM) is necessary to avoid further complications. This study was performed to compare the efficacy of insulin Glargine and Aspart with NPH insulin and regular insulin regimen in a group of children with T1DM.

METHODS: Forty patients with T1DM were enrolled in this study. During run-in, all subjects were treated with conventional therapy consisting of twice-daily NPH and thrice-daily regular. Following randomization, 20 subjects received Glargine and Aspart and 20 subjects received NPH and Regular insulin.

FINDINGS: Mean HbA1c was 8.8% and 8.6% at first and 8.4% and 8.2% at the end of study for subjects randomized initially to Glargine and Aspart and for those randomized to NPH and Regular, respectively (P>0.05). Mean fasting blood glucose (FBS) of the subjects randomized initially to Glargine and Aspart was 217±101 mg/dL, with no significant difference to 196±75 mg/dL for those randomized to NPH and Regular (P=0.48). This was also true at the end of the study. The difference in total cholesterol and triglyceride between the two groups in the beginning of study and at the end did not show any significance.

CONCLUSION: The current study showed no significant difference in glycemic control [Glycated hemoglobin (HbA1c) and FBS] and lipid profile (total cholesterol and triglyceride) between two regimes.

Keywords: Conventional Therapy; Insulin Aspart; Insulin Glargine; Type 1 Diabetes Mellitus

References

  1. Diabetes Care. 1984 Mar-Apr;7(2):188-99 - PubMed
  2. Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):545-53 - PubMed
  3. Diabetologia. 1999 Oct;42(10):1151-67 - PubMed
  4. Diabetes Technol Ther. 2004 Oct;6(5):589-95 - PubMed
  5. Pediatrics. 2008 Mar;121(3):e466-72 - PubMed
  6. Diabetes Res Clin Pract. 2007 Aug;77(2):215-22 - PubMed
  7. Diabet Med. 2001 Aug;18(8):619-25 - PubMed
  8. Endocr J. 2011;58(2):131-5 - PubMed
  9. Diabetes Care. 1997 Oct;20(10):1556-61 - PubMed
  10. Pediatr Diabetes. 2009 May;10(3):168-76 - PubMed
  11. Acta Biomed. 2003;74 Suppl 1:21-5 - PubMed
  12. BMJ. 2006 Jul 8;333(7558):65 - PubMed
  13. N Engl J Med. 1993 Sep 30;329(14):977-86 - PubMed
  14. Diabetes Res Clin Pract. 1990 Nov-Dec;10(3):221-30 - PubMed
  15. Diabetes Res Clin Pract. 1989 Jan 3;6(1):37-43 - PubMed
  16. Diabetes Care. 2000 May;23(5):639-43 - PubMed
  17. JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):23-36 - PubMed
  18. J Pediatr Nurs. 2005 Apr;20(2):83-95 - PubMed
  19. Diabetes Res Clin Pract. 2007 Apr;76(1):111-8 - PubMed
  20. Diabetes Care. 1983 Jul-Aug;6(4):374-7 - PubMed
  21. Diabetes Technol Ther. 2011 May;13(5):579-85 - PubMed
  22. Vojnosanit Pregl. 2007 Apr;64(4):247-52 - PubMed
  23. Rev Med Suisse. 2010 Jun 9;6(252):1199-200, 1202-4 - PubMed
  24. BMC Med. 2012 Jan 10;10:3 - PubMed
  25. Diabetes. 2012 Mar;61(3):683-6 - PubMed

Publication Types